US 11377643
Therapeutics for glycogen storage disease type III
granted A61KA61K31/7115A61K48/00
Quick answer
US patent 11377643 (Therapeutics for glycogen storage disease type III) held by Ultragenyx Pharmaceutical Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7115, A61K48/00, A61K48/0041, A61K48/005